Abstract
24.1 Introduction In recent years, opportunistic fungi have emerged as leading causes of morbidity and mortality in immunocompromised individuals [1,2]. The epidemiology of invasive fungal infections has evolved over the past two decades, partially because of the widespread use of antifungal agents with good activity against Candida, such as fluconazole. Since the early 1990s, ubiquitous airborne saprophytic molds have become the leading fungal pathogens in severely immunocompromised patients [1]. Aspergillus is the most common of these molds, and invasive aspergillosis (IA) has emerged as the major problem of modern mycology [2].
Original language | English (US) |
---|---|
Title of host publication | The Aspergilli |
Subtitle of host publication | Genomics, Medical Aspects, Biotechnology, and Research Methods |
Publisher | CRC Press |
Pages | 413-426 |
Number of pages | 14 |
ISBN (Electronic) | 9781420008517 |
ISBN (Print) | 9780849390807 |
DOIs | |
State | Published - Jan 1 2007 |
Externally published | Yes |
ASJC Scopus subject areas
- General Agricultural and Biological Sciences
- General Biochemistry, Genetics and Molecular Biology
- General Immunology and Microbiology